
Options for Alcohol-Associated Liver Disease Therapies Should Include Metabolic Risk
A new appreciation for the impact of metabolic risk factors in ALD may open avenues for new treatments.
A new appreciation for the impact of metabolic risk factors in ALD may open avenues for new treatments.
Dr. Brian Lee urges hepatologists to address upstream causes using evidence-based approaches.
In honor of September being Women in Medicine Month, we’re recognizing some of our female speakers from DDW 2021.
Groundbreaking developments in HIV treatments have slowly begun to transition the disease into a chronic condition. Thankfully, patients are able to live long and full
Varices and variceal hemorrhage are important and challenging complications that lead to decreased survival in patients with cirrhosis. Their proper management will lead to improvement in survival, according to presenters in Monday’s AASLD Clinical Symposium “Update on the Management of Gastroesophageal Varices.”
As Monday’s AASLD State-of-the-Art “New Hope for HCC” lecturer Laura Kulik, MD, notes, “15 years ago, an hour on the treatment of liver cancer would have been very difficult.” But now, a one-hour update is not only possible, but important for gastroenterologists.